OptimizeRx Secures $35 Million Senior Credit Facility to Support Growth

OptimizeRx Corp. announced a $35 million senior credit facility with Fifth Third Bank, including a $25 million term loan and a $10 million revolving credit facility, to bolster its financial flexibility for strategic initiatives.

Phoenix Metrowire Staff
Healthcare
OptimizeRx Secures $35 Million Senior Credit Facility to Support Growth

OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction. This strategic move provides OptimizeRx with additional capital to support its growth initiatives, including potential acquisitions and investments in its AI-driven platform.

The credit facility is expected to enhance the company's financial flexibility as it continues to expand its suite of digital health solutions. OptimizeRx's platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between healthcare provider (HCP) and direct-to-consumer (DTC) strategies, the company empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

According to the announcement, the company remains committed to privacy-safe, patient-centric technology, ensuring that every interaction is designed to make a meaningful impact. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape. The new credit facility underscores the confidence that financial institutions have in OptimizeRx's business model and growth trajectory.

For more details on the announcement, visit https://ibn.fm/G0Fj3. This funding comes at a time when the healthcare technology sector is increasingly focused on data-driven patient engagement solutions. OptimizeRx's AI-powered tools enable life sciences companies to reach patients and providers with precision, potentially improving medication adherence and health outcomes. The company's ability to secure a significant credit facility from a major bank like Fifth Third Bank signals strong market confidence and provides a solid foundation for future growth.

Blockchain Registration

QR Code for Blockchain Registration